欢迎来到 FabGennix中国区代理商/公司/官网
全国咨询热线: 18327026838
联系我们

地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301

电话:18372041646

传真:18771997407

邮箱:sales@amyjet.com

新闻中心
Anogen.jpg

Anogen-Yes Biotech Laboratories Ltd. 创建于1989年, 位于加拿大多伦多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技术研究有限公司在国际上的市场经销部门。Anogen-Yes Biotech Laboratories Ltd.研发和生产各种新颖抗体及有关产品,应用广泛的技术平台设计和开发各种单克隆抗体、多克隆抗体、基因工程/人源化抗体、免疫检验用配对抗体、免疫球蛋白、活性多肽、酶联免疫试剂盒[ELISA]、斑点酶联免疫试剂盒[Elispots]和基因重组蛋白质等等。 这些产品主要用于生命科学研究和各种疾病的诊断和防治,包括炎症和自身免疫性疾病、心血管病和癌症等。

 

Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian biopharmaceutical company based in Mississauga, Ontario. Founded in 1989, Anogen-Yes Biotech specializes in developing and manufacturing monoclonal antibodies, recombinant proteins, synthetic bioactive peptides, and Enzyme linked immunosorbent assay (ELISA) kits for research as well as diagnostic and therapeutic use.[1] It is also committed to seeking medical treatment of cancer, autoimmune, inflammatory and cardiovascular diseases by developing antibody-based biopharmaceuticals.

 

Anogen的主要产品包括:

Monoclonal Antibodies

Polyclonal Antibodies

Matched Antibody Pairs

ELISA Kits

 

按照研究领域细分:

Inflammatory & Growth Factors

Cell Biology & Molecular Biology

Immunoassay Reagents

Infection & Toxin

Coagulation Factors

Hormone

Neurological Disorder

Tumor Research


品名货号规格
mAb anti-Human TNF-α, CH8810MO-C40003A0.1 mg
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, C2H9MO-C40003D0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, C2A7MO-C40003F0.1 mg
mAb anti-Human TNF-α, C5G7MO-C40003G0.1 mg
mAb anti-Human TNF-α, C4C7MO-C40003H0.1 mg
mAb anti-Human IFN-γ, 315MO-C40004D0.1 mg
mAb anti-Human IFN-γ, 165MO-C40004E0.1 mg
mAb anti-Human IFN-γ, 23MO-C40004F0.1 mg
mAb anti-Human CCR1, 293MO-C40005A0.1 mg
mAb anti-Human TGF-β, TB21MO-C40009A0.1 mg
mAb anti-Human TGF-β, 2C5MO-C40009B0.1 mg
mAb anti-Human TGF-β, 2C6MO-C40009D0.1 mg
mAb anti-Human TGF-β, 2E6MO-C40009E0.1 mg
mAb anti-Human TGF-β, 8C4MO-C40009F0.1 mg
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-61MO-C40017E0.1 mg
mAb anti-Human IL-8, 257MO-C40017F0.1 mg
mAb anti-Human IL-8, 807MO-C40017G0.1 mg
mAb anti-Human MCP-1, S8MO-C40021A0.1 mg
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, 9G10MO-C40021E0.1 mg
mAb anti-Human MCP-1, S382MO-C40021F0.1 mg
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 513MO-C40028D0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 291MO-C40028G0.1 mg
mAb anti-Human SAA, 504MO-C40028H0.1 mg
mAb anti-Human SAA, 585MO-C40028J0.1 mg
mAb anti-Human SAA, 426MO-C40028K0.1 mg
mAb anti-Human SAA, 38MO-C40028L0.1 mg
mAb anti-Human SAA, 132MO-C40028M0.1 mg
mAb anti-Human SAA, S3MO-C40028N0.1 mg
mAb anti-Human IL-1β, S1H12MO-C40029A0.1 mg
mAb anti-Human IL-1β, S1B7MO-C40029B0.1 mg
mAb anti-Human IL-1β, S3F12MO-C40029G0.1 mg
mAb anti-Human IL-1β, 464MO-C40029H0.1 mg
mAb anti-Human IL-2, 5A8,MO-C40032A0.1 mg
mAb anti-Human IL-2, 9F9,MO-C40032B0.1 mg
mAb anti-Human IL-2, 10C4MO-C40032C0.1 mg
mAb anti-Human IL-2, 8C2MO-C40032D0.1 mg
mAb anti-Human IL-2, 6F11MO-C40032E0.1 mg
mAb anti-Human IL-2, 6B1MO-C40032F0.1 mg
mAb anti-Human EGF, S-21MO-C40044A0.1 mg
mAb anti-Human EGF, S-120MO-C40044B0.1 mg
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-145MO-C40044E0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-147MO-C40044G0.1 mg
mAb anti-Human EGF, S-177MO-C40044H0.1 mg
mAb anti-Human G-CSFR, S-1252MO-C40045A0.1 mg
mAb anti-Human G-CSFR, S-1268MO-C40045B0.1 mg
mAb anti-Human G-CSFR, S-1284MO-C40045D0.1 mg
mAb anti-Human G-CSFR, S-1374MO-C40045E0.1 mg
mAb anti-Human G-CSFR, S-425MO-C40045F0.1 mg
mAb anti-Human G-CSFR, S-1390MO-C40045G0.1 mg
mAb anti-Human bFGF, F-343MO-C40046A0.1 mg
mAb anti-Human bFGF, F-74MO-C40046B0.1 mg
mAb anti-Human bFGF, F-474MO-C40046F0.1 mg
mAb anti-Human bFGF, F-3MO-C40046H0.1 mg
mAb anti-Human EPO, 85MO-C40047A0.1 mg
mAb anti-Human M-CSF, 116MO-C40048A0.1 mg
mAb anti-Human M-CSF, 692MO-C40048B0.1 mg
mAb anti-Human M-CSF, 21MO-C40048D0.1 mg
mAb anti-Human MIP-1α, 116MO-C40051A0.1 mg
mAb anti-Human MIP-1α, 125MO-C40051D0.1 mg
mAb anti-Human MIP-1α, 548MO-C40051F0.1 mg
mAb anti-Human MIP-1α, 199MO-C40051G0.1 mg
mAb anti-Human MIP-1α, 400MO-C40051L0.1 mg
mAb anti-Human MIP-1α, 103MO-C40051M0.1 mg
mAb anti-Human MIP-1α, 376MO-C40051N0.1 mg
mAb anti-Human MIP-1α, 426MO-C40051P0.1 mg
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 343MO-C40088B0.1 mg
mAb anti-Human MCP-3, 490MO-C40088D0.1 mg
mAb anti-Human MCP-3, 768MO-C40088E0.1 mg
mAb anti-Human MCP-3, 1057MO-C40088F0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 1015MO-C40088H0.1 mg
mAb anti-Human IL-16, 59MO-C40089G0.1 mg
mAb anti-Human IL-16, 210MO-C40089H0.1 mg
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 568MO-C40089M0.1 mg
mAb anti-Human IL-16, 572MO-C40089N0.1 mg
mAb anti-Human GM-CSF, 29MO-C40090A0.1 mg
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 204MO-C40090E0.1 mg
mAb anti-Human GM-CSF, 489MO-C40090F0.1 mg
mAb anti-Human GM-CSF, 120MO-C40090G0.1 mg
mAb anti-Human GM-CSF, 26MO-C40090H0.1 mg
mAb anti-Human GM-CSF, 174MO-C40090K0.1 mg
mAb anti-Human GM-CSF, S333MO-C40090L0.1 mg
mAb anti-Human IL-6, 2E10MO-C40091B0.1 mg
mAb anti-Human IL-6, 8E10MO-C40091C0.1 mg
mAb anti-Human IL-6, 5G8MO-C40091D0.1 mg
mAb anti-Human IL-6, 1B6MO-C40091E0.1 mg
mAb anti-Human IL-6, 1E3MO-C40091F0.1 mg
mAb anti-Human IL-6, 6D7MO-C40091G0.1 mg
mAb anti-Human IL-6, 9D8MO-C40091H0.1 mg
mAb anti-Human IL-10, 4H2MO-C40092A0.1 mg
mAb anti-Human IL-10, 6D2MO-C40092B0.1 mg
mAb anti Human IL-17A clone 4C1, CaptureMO-C40093A0.1mg
mAb anti Human IL-17A clone 2F3MO-C40093B0.1mg
mAb anti Human IL-17A clone 8H7MO-C40093C0.1mg
mAb anti Human IL-17A clone 5B4MO-C40093D0.1mg
mAb anti Human IL-17A clone 1E2MO-C40093E0.1mg
mAb anti Human IL-17A clone 2D11MO-C40093H0.1mg
mAb anti Human IL-17A clone 3C1MO-C40093I0.1mg
mAb anti Human IL-17A clone 3H11, DetectorMO-C40093K0.1mg
mAb anti Human IL-17A clone 5A9MO-C40093M0.1mg
mAb anti Human IL-17A clone 6F12MO-C40093O0.1mg
mAb anti Human IL-17A clone 7F10MO-C40093S0.1mg
mAb anti Human IL-17A clone 10F9MO-C40093W0.1mg
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti-human LIF, Clone 2C6MO-C40096A0.1mg
mAb anti-human LIF, Clone 3F4MO-C40096B0.1mg
mAb anti-human LIF, Clone 8B10MO-C40096C0.1mg
mAb anti-DYKDDDDK (Flag) Tag, Flag.10F4MO-H40001B0.1 mg
mAb anti-GAPDH, H8MO-H40002A0.1 mg
mAb anti-HA Tag, HA52MO-H40004A0.1 mg
mAb anti-His Tag, 10A12MO-H40005B0.1 mg
mAb anti-Myc Tag, MycA7MO-H40006A0.1 mg
mAb anti-V5 Tag, V531MO-H40007A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 163MO-I40002C0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 587, 0.1 mgMO-I40002E0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 425MO-I40002I0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 1027MO-I40002J0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 287MO-I40002N0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 161MO-I40002P0.1 mg
mAb anti-HBsAg, RM-1MO-I40013A0.1 mg
mAb anti-HCV Core Protein, A1/3D1MO-I40015A0.1 mg
mAb anti-HCV Core Protein, B2MO-I40015B0.1 mg
mAb anti-HCV Core Protein, C3MO-I40015E0.1 mg
mAb anti-HCV NS-4, 7B7/5G9MO-I40016B0.1 mg
mAb anti-HCV NS-4, 5D4/10E7MO-I40016D0.1 mg
mAb anti-HCV NS-4, 7E11MO-I40016F0.1 mg
mAb anti-HCV NS-4, 202MO-I40016J0.1 mg
mAb anti-HCV NS-4, 101MO-I40016K0.1 mg
mAb anti-HCV NS-4, 174MO-I40016L0.1 mg
mAb anti-HCV NS-4, 497MO-I40016M0.1 mg
mAb anti-HCV NS-3, 70-13MO-I40018A0.1 mg
mAb anti-HCV NS-3, 1-5MO-I40018B0.1 mg
mAb anti-HCV NS-3, 12-15MO-I40018D0.1 mg
mAb anti-HCV NS-3, 5-11MO-I40018E0.1 mg
mAb anti-HCV NS-3, 24-8MO-I40018F0.1 mg
mAb anti-HCV NS-3, 20-8MO-I40018G0.1 mg
mAb anti-HCV NS-3, 113MO-I40018H0.1 mg
mAb anti-HCV NS-3, 281MO-I40018J0.1 mg
mAb anti-HCV NS-3, 806MO-I40018K0.1 mg
mAb anti-HCV NS-3, 5MO-I40018L0.1 mg
mAb anti-HCV NS-3, 328MO-I40018M0.1 mg
mAb anti-HCV NS-3, 251MO-I40018N0.1 mg
mAb anti-HCV NS-3, 242MO-I40018P0.1 mg
mAb anti-HCV NS-3, 133MO-I40018Q0.1 mg
mAb anti-HEV, S-13MO-I40019B0.1 mg
mAb anti-HEV, 4H5MO-I40019C0.1 mg
mAb anti-HEV, 2H6MO-I40019D0.1 mg
mAb anti-HEV, 2H2MO-I40019E0.1 mg
mAb anti-HEV, 1B6MO-I40019F0.1 mg
mAb anti-HEV, 5H4MO-I40019G0.1 mg
mAb anti-HP CagA, 10E9,MO-I40020A0.1 mg
mAb anti-HP CagA, 5H10MO-I40020B0.1 mg
mAb anti-HP CagA, 5C6MO-I40020C0.1 mg
mAb anti-HP CagA, 3C10,MO-I40020D0.1 mg
mAb anti-HP CagA, 3C1MO-I40020E0.1 mg
mAb anti-TB 38KD Antigen, D2G2MO-I40021A0.1 mg
mAb anti-TB 38KD Antigen, C12H11MO-I40021B0.1 mg
mAb anti-TB 38KD Antigen, C11B10MO-I40021C0.1 mg
mAb anti-TB 38KD Antigen, B12F8MO-I40021D0.1 mg
mAb anti-TB 38KD Antigen, A11D2MO-I40021E0.1 mg
mAb anti-TB 38KD Antigen, A2H8MO-I40021F0.1 mg
mAb anti-Human CD3, JXT3MO-L40001A0.1 mg
Rat anti-Mouse CD4, JXYT4MO-L400260.1 mg
Rat anti-Mouse CD8, JXYT8MO-L400270.1 mg
mAb anti-Human CD11α, A11MO-L400280.1 mg
mAb anti-Human HLA-ABC, LY5.1MO-L400330.1 mg
mAb anti-Human CD71 Transferrin Receptor, CY-TFRMO-L400420.1 mg
mAb anti-Human PD-1 / CD279, 1C4MO-L40043A0.1 mg
mAb anti-Human PD-1 / CD279, 7C9, CaptureMO-L40043B0.1 mg
mAb anti-Human PD-1 / CD279, 9E11MO-L40043E0.1 mg
mAb anti-Human PD-1 / CD279, 9B4MO-L40043F0.1 mg
mAb anti-Human PD-1 / CD279, B1C4MO-L40043G0.1 mg
mAb anti-Human PD-1 / CD279, 7G12, DetectorMO-L40043L0.1 mg
mAb anti-Human PD-1 / CD279, 2H7MO-L40043M0.1 mg
mAb anti Human PD-L1, clone 6A5MO-L40044E0.1 mg
mAb anti Human PD-L1 clone 8C12MO-L40044F0.1 mg
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 11D11MO-L40044M0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti Human PD-L1 clone 12D9MO-L40044O0.1 mg
mAb anti Human PD-L1 clone 15F2MO-L40044R0.1 mg
mAb anti Human PD-L1, clone 10B12MO-L40044S0.1 mg
mAb anti Human CD47, clone 1G10MO-L40045A0.1 mg
mAb anti Human CD47, clone 8H7MO-L40045B0.1 mg
mAb anti Human CD47, clone 9F10MO-L40045C0.1 mg
mAb anti Human CD44, clone 2G7MO-L40046A0.1 mg
mAb anti Human CD44, clone 3C7MO-L40046B0.1 mg
mAb anti-hCG-α, CH5MO-M40010A0.1 mg
mAb anti-hCG-α, CH7MO-M40010B0.1 mg
mAb anti-TRICHOSANTHIN (TCST), TCST-1, 0.1 mgMO-M40011A0.1 mg
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-Human Ig Kappa Light Chain, YCK1MO-M400200.1 mg
mAb anti-Human B2MG, D6E4MO-M40021B0.1 mg
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D6D1MO-M40021D0.1 mg
mAb anti-Human B2MG, D2A10MO-M40021E0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human CRP, 67A1MO-M40023B0.1 mg
mAb anti-human CRP, N1G1MO-M40023D0.1 mg
mAb anti-human CRP, S5G1MO-M40023E0.1 mg
mAb Rat anti-Aflatoxin, 1C6, 0.1 mgMO-M40025A0.1 mg
mAb Rat anti-Aflatoxin, 1E6, 0.1 mgMO-M40025B0.1 mg
mAb Rat anti-Aflatoxin, 2E4MO-M40025D0.1 mg
mAb anti-Human Albumin, S4D6MO-M400360.1 mg
mAb anti-Human Factor IX, F9-1, .01 mgMO-M400370.1 mg
mAb anti-Human Protein C, HLW-C, 0.1 mgMO-M400380.1 mg
mAb anti-Human Factor X, F10-1, 0.1 mgMO-M400390.1 mg
mAb anti-Human GP IIb/IIIa, 237, 0.1 mgMO-M40040A0.1 mg
mAb anti-Human GP IIb/IIIa, 474, 0.1 mgMO-M40040B0.1 mg
mAb anti-Human GP IIb/IIIa, Y8MO-M40040D0.1 mg
mAb anti-Human GP IIb/IIIa, 700MO-M40040E0.1 mg
mAb anti-Human GP IIb/IIIa, 585MO-M40040F0.1 mg
mAb anti-Human GP IIb/IIIa, 8MO-M40040H0.1 mg
mAb anti-Human GP IIb/IIIa, 291MO-M40040J0.1 mg
mAb anti-Human GP IIb/IIIa, 262MO-M40040N0.1 mg
mAb anti-Human GP IIb/IIIa, 71MO-M40040Q0.1 mg
mAb anti-Human GP IIb/IIIa, 128MO-M40040S0.1 mg
mAb anti-Staphylococcal Enterotoxin B [SEB], 0.1 mgMO-M400410.1 mg
mAb anti-Human PTP1-C, PTY6MO-M40043A0.1 mg
mAb anti-Human PTP1-C, PTY11MO-M40043B0.1 mg
mAb anti-Human PTP1-C, PTY15MO-M40043D0.1 mg
mAb anti-Human PTP1-C, PTY10MO-M40043E0.1 mg
mAb anti-Human PTP1-C, PTY13MO-M40043F0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human Raf-1, 410MO-M40091E0.5 mg
mAb anti-Human Raf-1, 540MO-M40091G0.5 mg
mAb anti-Human Raf-1, 863MO-M40091J0.5 mg
mAb anti-Human Raf-1, 163MO-M40091M0.5 mg
mAb anti-Human NSE, 145MO-M40092A0.5 mg
mAb anti-Human NSE, 1G6MO-M40092B0.5 mg
mAb anti-Human NSE, 171MO-M40092C0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3B3MO-M40093A0.1 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 3F8MO-M40093D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 3F5MO-M40094A0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1H3MO-M40094B0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 6C8MO-M40094C0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4A2MO-M40094E0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7H7MO-M40094F0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 5A4MO-M40094G0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 4B7MO-M40094H0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 7G10MO-M40094I0.5 mg
mAb anti-Amyloid β Peptide N-terminal, NT 1F10MO-M40094J0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 8B2MO-M40095B0.1 mg
mAb anti-Amyloid β Peptide 40, 4B1MO-M40095C0.1 mg
mAb anti-Human α1-antitrypsin, 5G5MO-M40096A0.1 mg
mAb anti-Human α1-antitrypsin, 9F2MO-M40096B0.1 mg
mAb anti-Human α-Synuclein, 4H11MO-M40097A0.1 mg
mAb anti-Human α-Synuclein, 4C1MO-M40097B0.1 mg
mAb anti-Human α-Synuclein, 4B4MO-M40097C0.1 mg
mAb anti-Human α-Synuclein, 8F12MO-M40097D0.1 mg
mAb anti-Human α-Synuclein, 9A9MO-M40097E0.1 mg
mAb anti-Human α1-antichymotrypsin, 3E11MO-M40098A0.1 mg
mAb anti-Human α1-antichymotrypsin, B2B3MO-M40098B0.1 mg
mAb anti-Human α1-antichymotrypsin, B4H12MO-M40098C0.1 mg
mAb anti-Human α1-antichymotrypsin, B5B11MO-M40098D0.1 mg
mAb anti-Human α1-antichymotrypsin, B7B10MO-M40098E0.1 mg
mAb anti-Human α1-antichymotrypsin, B7H2MO-M40098F0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 1A4MO-M40099A0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 7G9MO-M40099B0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 9B4MO-M40099C0.1 mg
mAb anti-Thr181 Phosphorylated Tau, 2A4MO-M40099D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1MO-M40100A0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 1G8MO-M40100B0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1MO-M40100C0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12MO-M40100D0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1MO-M40100E0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11MO-M40100F0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11MO-M40100G0.1 mg
mAb anti-human Thr212 Thr217 double phosphorylated Tau, 10G9MO-M40100H0.1 mg
mAb anti-LCRMP4, 5H5MO-M40101A/
mAb anti-LCRMP4, 2H7MO-M40101B/
mAb anti-LCRMP4 , 7E1MO-M40101C/
mAb anti-Human Phospho-STAT5b [p-Y699], A4B9MO-P40001A0.1 mg
mAb anti-Human Phospho-STAT5b [p-Y699], A2H6MO-P40001B0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], B4A12MO-P40002A0.1 mg
mAb anti-Human Phospho-ELK-1 [p-S383], D7H2MO-P40002B0.1 mg
mAb anti-Human Phospho-CREB [p-S133], A3A4MO-P40003A0.1 mg
mAb anti-Human Phospho-CREB [p-S133], B1C4MO-P40003B0.1 mg
mAb anti-Human FPRL-1 C-terminal, C4F9MO-P40006A0.1 mg
mAb anti-Human FPRL-1 C-terminal, B4D9B10MO-P40006B0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, 3D7MO-P40007A0.1 mg
mAb anti-Human FPRL-1 2nd extracellular loop, B7H10MO-P40007B0.1 mg
mAb anti-Human Lung Carcinoma, CHALU2MO-T40005B0.1 mg
mAb anti-Human Lung Carcinoma, 3504MO-T40005C0.1 mg
mAb anti-Human Hepatocellular Carcinoma, CHALV1MO-T40006A0.1 mg
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human BPH, YBPH-1MO-T40008A0.1 mg
mAb anti-Human BPH, YBPH-2MO-T40008B0.1 mg
mAb anti-Human PML, B3E9MO-T40010A0.1 mg
mAb anti-Human PML, B4C8MO-T40010B0.1 mg
mAb anti-CA 125, 110MO-T40012A0.1 mg
mAb anti-CA 125, 76MO-T40012B0.1 mg
mAb anti-CA 125, 23MO-T40012C0.1 mg
mAb anti-CA 125, 15MO-T40012D0.1 mg
mAb anti-CA 125MO-T40012E0.1 mg
mAb anti-CA50, 93MO-T40014A0.1 mg
mAb anti-CA50, 826MO-T40014B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,8E2 (Free Sample Available)MO-T40015A0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9B2 (Free Sample Available)MO-T40015B0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,1A5 (Free Sample Available)MO-T40015C0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,4E11 (Free Sample Available)MO-T40015D0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9E1 (Free Sample Available)MO-T40015E0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7C4 (Free Sample Available)MO-T40015F0.1 mg
mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7E6 (Free Sample Available)MO-T40015G0.1 mg
mAb anti-Human Colorectal Carcinoma, Y94MO-T400220.1 mg
mAb anti-Human Colorectal Carcinoma/CD3, BS-1MO-T400350.1 mg
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PMA, YPMA-1MO-T40083A0.1 mg
mAb anti-Human PMA, YPMA-2MO-T40083B0.1 mg
mAb anti-Human PSP, YPSP-1MO-T40085A0.1 mg
mAb anti-Human PSP, YPSP-2MO-T40085B0.1 mg
mAb anti-Human PSP, YPSP-3MO-T40085C0.1 mg
mAb anti-Human PSP, YPSP-4MO-T40085D0.1 mg
mAb anti-Human PSMA, YPSMA-1MO-T40086A0.1 mg
mAb anti-Human PSMA, YPSMA-2MO-T40086B0.1 mg
mAb anti-Human PSMA, 4H11MO-T40086C0.1 mg
mAb anti-Human PSMA, 7F3MO-T40086D0.1 mg
mAb anti-Human PTMA, 8H12MO-T40087A0.1 mg
mAb anti-Human PTMA, 9A10MO-T40087B0.1 mg
mAb anti-Human PTMA, 6A3MO-T40087C0.1 mg
mAb anti-Human PTMA, 4G2MO-T40087D0.1 mg
mAb anti-Human PTMA, 5A10MO-T40087E0.1 mg
mAb anti-Human PTMA, 6H7MO-T40087F0.1 mg
mAb anti-Human PTMA, 1F2, CaptureMO-T40087G0.1 mg
mAb anti-Human PTMA, 4C3MO-T40087H0.1 mg
mAb anti-Human PTMA, 4A7, DetectorMO-T40087I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9A4MO-T40088A0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E6MO-T40088B0.1 mg
mAb anti-Human S100A7 (psoriasin), 1A10MO-T40088C0.1 mg
mAb anti-Human S100A7 (psoriasin), 5C2MO-T40088D0.1 mg
mAb anti-Human S100A7 (psoriasin), 10H9MO-T40088E0.1 mg
mAb anti-Human S100A7 (psoriasin), 2A3MO-T40088F0.1 mg
mAb anti-Human S100A7 (psoriasin), 2E5MO-T40088G0.1 mg
mAb anti-Human S100A7 (psoriasin), 5H12MO-T40088H0.1 mg
mAb anti-Human S100A7 (psoriasin), 9C7MO-T40088I0.1 mg
mAb anti-Human S100A7 (psoriasin), 9D5MO-T40088J0.1 mg
mAb anti-Human S100A7 (psoriasin), 3E7MO-T40088K0.1 mg
Human PSA ELISA KitEL1000596 wells
Human IL-8 ELISA KitEL1000896 wells
Human MCAF / MCP-1 ELISA KitEL1000996 wells
Human EGF ELISA KitEL1001096 wells
Human LH ELISA KitEL1001196 wells
Human TSH ELISA KitEL1001296 wells
Neonatal TSH ELISA KitEL10012N96 wells
Ultra-Sensitive Human TSH ELISA KitEL10012U96 wells
Human FSH ELISA KitEL1001396 wells
Human Prolactin ELISA KitEL1001496 wells
Human SAA ELISA KitEL1001596 wells
Human SAA ELISA Kit (2nd Generation)EL10015L96 wells
Human MCP-3 ELISA KitEL1001696 wells
Human TNF-α ELISA KitEL1001996 wells
Human GM-CSF ELISA KitEL1002096 wells
Human IL-16 ELISA KitEL1002196 wells
High Sensitivity Human CRP ELISA KitEL10022hs96 wells
Human IL-6 ELISA KitEL1002396 wells
Human IFN-γ ELISA KitEL1002496 wells
Human IL-2 ELISA KitEL1002596 wells
Human IL-4 ELISA KitEL1002696 wells
Human IL-10 ELISA KitEL1002796 wells
Human IL-1β ELISA KitEL1002896 wells
Human TGF-β1 ELISA KitEL1002996 wells
Human Growth Hormone (hGH) ELISA Kit/Hormone ElisaEL1003096 wells
High Sensitivity Human Growth Hormone (H-hGH) ELISA KitEL10030H96 wells
Human Chorionic Gonadotropin (hCG) ELISA KitEL1003196 wells
Human IL-12 (P70) ELISA KitEL1003296 wells
Human IL-2 sRα ELISA KitEL1003396 wells
Human IL-6 sR ELISA KitEL1003496 wells
Human IL-5 ELISA KitEL1003596 wells
HAMA ELISA KitEL1003696 wells
Human IL-13 Rα2 ELISA KitEL1003996 wells
Human IL-1α ELISA KitEL1004096 wells
Human IL-7 ELISA KitEL1004196 wells
Human IL-11 ELISA KitEL1004296 wells
Human IL-15 ELISA KitEL1004496 wells
Human M-CSF ELISA KitEL1004696 wells
Human TNF-β ELISA KitEL1004796 wells
Human bFGF ELISA KitEL1004896 wells
Human Alphafetoprotein (AFP) ELISA KitEL1004996 wells
Human B2MG ELISA KitEL1005196 wells
Human Carcinoembryonic Antigen (CEA) ELISA KitEL1005296 wells
Human IL-17A ELISA KitEL1005396 wells
Human IL-13 ELISA KitEL1005496 wells
Human IL-22 ELISA KitEL1005596 wells
Human IL-9 ELISA KitEL1005696 wells
Human Amyloid Beta Peptide 42 ELISA KitEL1005796 wells
Human Programmed Death-Ligand 1 (PD-L1) ELISA KitEL1005896 wells
Human Programmed Death-1 (PD-1) ELISA KitEL1005996 wells
Human IL-18 ELISA KitEL1006096 wells
Multiplex Human Cytokine ELISA Kit (Inflammatory)EM1000196 wells
Multiplex Human Cytokine ELISA Kit (M1/M2/MDSC Cytokines)EM1000296 wells
Multiplex Human Cytokine ELISA Kit (Th1/Th2/Th17)EM1000396 wells
Mouse IL-17A ELISA KitMEC100196 wells
Mouse IFN-γ ELISA KitMEC100296 wells
Mouse TNF-α ELISA KitMEC100396 wells
Mouse GM-CSF ELISA KitMEC100496 wells
Mouse MCP-1 ELISA KitMEC100596 wells
Mouse IL-2 ELISA KitMEC100696 wells
Mouse IL-5 ELISA KitMEC100796 wells
Mouse IL-6 ELISA KitMEC100896 wells
Mouse IL-4 ELISA KitMEC100996 wells
Mouse IL-1β ELISA KitMEC101096 wells
Mouse IL-1α ELISA KitMEC101196 wells
Mouse TGF-β1 ELISA KitMEC101296 wells
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
mAb anti-Human TNF-α, CH8820, CaptureMO-C40003B0.1 mg
mAb anti-Human TNF-α, B1E4, DetectorMO-C40003E0.1 mg
mAb anti-Human TNF-α, B1E4, Tracer (HRP Labeled)MO-C40003T0.2 mL
mAb anti-Human TNF-α, B1E4, Tracer (Biotin Labeled)MO-C40003TB0.1 mL
mAb anti-Human IL-8, I8-S2, CaptureMO-C40017A0.1 mg
mAb anti-Human IL-8, I8-60, DetectorMO-C40017D0.1 mg
mAb anti-Human IL-8, I8-60, Tracer (HRP Labeled)MO-C40017T0.2 mL
mAb anti-Human IL-8, I8-60, Tracer (Biotin Labeled)MO-C40017TB0.1 mL
mAb anti-Human MCP-1, S14, CaptureMO-C40021B0.1 mg
mAb anti-Human MCP-1, S101, DetectorMO-C40021D0.1 mg
mAb anti-Human MCP-1, S101, Tracer (HRP Labeled)MO-C40021T0.2 mL
mAb anti-Human MCP-1, S101, Tracer (Biotin Labeled)MO-C40021TB0.1 mL
mAb anti-Human SAA, 115, CaptureMO-C40028A0.1 mg
mAb anti-Human SAA, 607, DetectorMO-C40028E0.1 mg
mAb anti-Human SAA, 607, Tracer (HRP Labeled), 0.2mLMO-C40028T0.2 mL
mAb anti-Human SAA, 607, Tracer (Biotin Labeled), 0.1mLMO-C40028TB0.1 mL
mAb anti-Human EGF, S-134, CaptureMO-C40044D0.1 mg
mAb anti-Human EGF, S-146, DetectorMO-C40044F0.1 mg
mAb anti-Human EGF, S-146, Tracer (HRP Labeled)MO-C40044T0.2 mL
mAb anti-Human EGF, S-146, Tracer (Biotin Labeled)MO-C40044TB0.1 mL
mAb anti-Human MCP-3, 113, DetectorMO-C40088A0.1 mg
mAb anti-Human MCP-3, 542, CaptureMO-C40088G0.1 mg
mAb anti-Human MCP-3, 113, Tracer (HRP Labeled)MO-C40088T0.2 mL
mAb anti-Human MCP-3, 113, Tracer (Biotin Labeled)MO-C40088TB0.1 mL
mAb anti-Human IL-16, 323, DetectorMO-C40089J0.1 mg
mAb anti-Human IL-16, 398, CaptureMO-C40089K0.1 mg
mAb anti-Human IL-16, 323, Tracer (HRP Labeled)MO-C40089T0.2 mL
mAb anti-Human GM-CSF, 59, CaptureMO-C40090B0.1 mg
mAb anti-Human GM-CSF, 429, DetectorMO-C40090D0.1 mg
mAb anti-Human GM-CSF, 429, Tracer (HRP Labeled)MO-C40090T0.2 mL
mAb anti-Human GM-CSF, 429, Tracer (Biotin Labeled)MO-C40090TB0.1 mL
mAb anti Human IL-18 clone 2A10, CaptureMO-C40094A0.1mg
mAb anti Human IL-18 clone 10H4, DetectorMO-C40094B0.1mg
mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled)MO-C40094TB0.1 mL
mAb anti Human IL-15 clone 5E8, CaptureMO-C40095A0.1mg
mAb anti Human IL-15 clone B1H6, DetectorMO-C40095B0.1mg
mAb anti human IL-15 clone B1H6, Tracer (Biotin labeled)MO-C40095TB0.1 mL
mAb anti-HIV-1 P24 (Core Protein), 473, DetectorMO-I40002A0.1 mg
mAb anti-HIV-1 P24 (Core Protein), 340, CaptureMO-I40002D20.1 mg
mAb anti-HIV-1 P24 (Core Protein), 473, Tracer (HRP), 0.2 mLMO-I40002T20.2 mL
mAb anti-Human PD-1 / CD279, 7G12, Tracer (Biotin labeled)MO-L40043TB0.1 mL
mAb anti Human PD-L1 clone 12B4, DetectorMO-L40044I0.1 mg
mAb anti Human PD-L1 clone 15G3, CaptureMO-L40044N0.1 mg
mAb anti human PD-L1 clone 12B4, Tracer (Biotin Labeled)MO-L40044TB0.1 mL
mAb anti-hGH, YC6, CaptureMO-M40012A0.1 mg
mAb anti-hGH, YC8, Tracer (HRP Labeled), 0.2 mLMO-M40012T0.2 mL
mAb anti-hGH, YC8, Tracer (Biotin Labeled), 0.1 mLMO-M40012TB0.1 mL
mAb anti-Human B2MG, D2E9, CaptureMO-M40021C0.1 mg
mAb anti-Human B2MG, D3A2, DetectorMO-M40021F0.1 mg
mAb anti-Human B2MG, D3A2, Tracer (HRP Labeled), 0.2mLMO-M40021T0.2 mL
mAb anti-human CRP, 63F4, CaptureMO-M40023A0.1 mg
mAb anti-human TSH, TSH-2, DetectorMO-M40046A0.1 mg
mAb anti-human TSH, TSH-1, CaptureMO-M40046B0.1 mg
mAb anti-human TSH, TSH-2, Tracer (HRP Labeled), 0.2 mLMO-M40046T0.2 mL
mAb anti-Human Prolactin, PRL-1, CaptureMO-M40047B0.5 mg
mAb anti-Human Prolactin, PRL-2, Tracer (HRP Labeled), 0.2 mLMO-M40047T0.2 mL
mAb anti-Human LH, LH-1, CaptureMO-M40048B0.5 mg
mAb anti-Human LH, LH-2, Tracer (HRP Labeled), 0.2 mLMO-M40048T0.2 mL
mAb anti-hCG, HCG-1, CaptureMO-M40049B0.5 mg
mAb anti-hCG, HCG-2, Tracer (HRP Labeled), 0.2 mLMO-M40049T0.2 mL
mAb anti-Human FSH, FSH-1, CaptureMO-M40050B0.5 mg
mAb anti-Human FSH, FSH-2, Tracer (HRP Labeled)MO-M40050T0.2 mL
mAb anti-Amyloid β Peptide 42, CA9 10C11, DetectorMO-M40093B0.5 mg
mAb anti-Amyloid β Peptide 42, CA9 10C11, Tracer (Biotin)MO-M40093TB0.1 mL
mAb anti-Amyloid β Peptide N-terminal, NT 5B8, CaptureMO-M40094D0.5 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, DetectorMO-M40095A0.1 mg
mAb anti-Amyloid β Peptide 40, CV9 7B10, Tracer (Biotin)MO-M40095TB0.1 mL
mAb anti-Human AFP, AFP-Y2, DetectorMO-T40007A0.1 mg
mAb anti-Human AFP, AFP-Y1, CaptureMO-T40007B0.1 mg
mAb anti-Human AFP, AFP-2, Tracer (HRP Labeled), 0.2 mLMO-T40007T0.2 mL
mAb anti-Human CEA, CEA-Y2, DetectorMO-T40051A0.1 mg
mAb anti-Human CEA, CEA-Y1, CaptureMO-T40051B0.1 mg
mAb anti-Human CEA, CEA-Y2, Tracer (HRP Labeled), 0.2 mLMO-T40051T0.2 mL
mAb anti-Human Free PSA, 103, DetectorMO-T40052A0.1 mg
mAb anti-Human Free PSA, 108, CaptureMO-T40052B0.1 mg
mAb anti-Human Free PSA, 103, Tracer (HRP Labeled), 0.2 mLMO-T40052T0.2 mL
mAb anti-Human PSA, CHYH1, CaptureMO-T40081A0.1 mg
mAb anti-Human PSA, CHYH2, DectectorMO-T40081B0.1 mg
mAb anti-Human PSA, CHYH2, Tracer (HRP Labeled), 0.2 mLMO-T40081T0.2 mL
Human Chorionic Gonadotrophin (hCG), 10 mgAP3000210 mg
Human Immunoglobulin G (IgG), 10 mgIG3000110 mg
Mouse Immunoglobulin G (IgG), 10 mgIG4100210 mg
Mouse Immunoglobulin G2b (IgG2b), 10 mgIG4100410 mg
Rat Immunoglobulin G (IgG)IG4200310 mg
Human Umbilical Cord Serum, 10 mLS3001010 mL
ELISA Coating (EC) Stabilizer, 500 mLS7001500 mL
Human IL-8 Matched Antibody Pair for ELISpotSL10008A5 × 96 wells
Human IL-8 Development Set for ELISpotSL10008B5 × 96 wells
Human IL-8 ELISpot KitSL10008E6 X 96 wells
Human MCAF (MCP-1) Matched Antibody Pair for ELISpotSL10009A5 × 96 wells
Human MCAF (MCP-1) Development Set for ELISpotSL10009B5 × 96 wells
Human MCAF (MCP-1) ELISpot KitSL10009E6 X 96 wells
Human GM-CSF Matched Antibody Pair for ELISpotSL10020A5 × 96 wells
Human GM-CSF Development Set for ELISpotSL10020B5 × 96 wells
Human GM-CSF ELISpot KitSL10020E6 X 96 wells
Human IFN-γ Matched Antibody Pair for ELISpotSL10024A5 × 96 wells
Human IFN-γ Development Set for ELISpotSL10024B5 × 96 wells
Human IFN-γ ELISpot KitSL10024E6 X 96 wells
Human IL-12 (P70) ELISpot KitSL10032E6 X 96 wells
TMB Solution (500 mL Part A & 500 mL Part B)SU60061.0 L
pAb Rabbit anti-HCV Virus, 1.0 mgAI20006P1.0 mg
pAb Rabbit anti-HIV-1 p24, 1.0 mgAI20008P1.0 mg
pAb anti-Human CRP, Tracer (HRP Labeled)AI20009P0.2 mL
pAb Rabbit anti-Mouse IgG , 1.0 mgAI500051.0 mg
pAb Rabbit anti-Mouse IgG - HRP Conjugated, 1.0 mLAI50005P1.0 mL
pAb Rabbit anti-hGH,AI50006P1.0 mg
pAb Chicken anti-human IL-8 (IgY fraction)AI600011.0 mg
pAb Rabbit anti-Human FPRL-1 2nd Extracellular LoopAI70001A0.1 mg
pAb Rabbit anti-Human FPRL-1 C-terminalAI70001B0.1 mg
pAb Rabbit anti-Human PML [Ring Finger Domain]AI70002A0.1 mg
pAb Rabbit anti-Human PML [B-box 1 domain]AI70002B0.1 mg
pAb Rabbit anti-Bcl-2AI70003A0.1 mg
pAb Rabbit anti-Phospho-Bcl-2 (Thr56)AI70003B0.1 mg
pAb Rabbit anti-Phospho-Bcl-xL (Thr115)AI70003D0.1 mg
pAb Rabbit anti-Phospho c-kit (Tyr719)AI70004A0.1 mg
pAb Rabbit anti-Phospho IKK-γ (Ser31)AI70005A0.1 mg
pAb Rabbit anti-NF-κB-p65 (RelA)AI70006A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser276)AI70007A0.1 mg
pAb Rabbit anti-Phospho-NF-қB-p65 (Ser468)AI70008A0.1 mg
pAb Rabbit anti-Phospho NF-қB-p105/p50 (Ser337)AI70009A0.1 mg
pAb Rabbit anti-Human Serum Albumin (HSA)AI800010.1 mg
pAb Rabbit anti-Human Fibrinogen, 0.1 mgAI800020.1 mg
pAb Rabbit anti-Human TransferrinAI800030.1 mg
pAb Rabbit anti-Human IgA, 0.5 mgAI800040.5 mg
pAb Rabbit anti-human IgM, 0.5 mgAI800050.5 mg
pAb Rabbit anti-Human TREK-1 (K2p2.1)AI80006A0.1 mg
pAb Rabbit anti-Mouse Kchip1AI800070.1 mg
pAb Rabbit anti-Mouse Kchip4AI800080.1 mg
pAb Rabbit anti-Mouse Kv4.3AI80010A0.1 mg
pAb Rabbit anti-Mouse TRPV1AI80011A0.1 mg
pAb Rabbit anti-Mouse TRPV3AI80012A0.1 mg
pAb Rabbit anti-Human JAK2AI80013A0.1 mg
pAb Rabbit anti-Human Glutathione S Transferase (GST), 0.1 mgAI800140.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 42AI900010.1 mg
pAb Rabbit anti-Human Amyloid beta peptide 43AI900020.1 mg


" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Anogen">
Anogen
...
阅读详情
669797ff94d9c.jpg

艾美捷科技代理SYnAbs品牌抗体。


SYnAbs公司针对免疫原性较差的化合物和复杂抗原进行开发,其抗体产品线范围包括:针对跨膜蛋白(GPCR、离子通道、转运蛋白)、类固醇、小分子、毒素、脂质和

多糖(针对真菌和细菌)的单克隆抗体。为了应对针对半抗原和膜蛋白产生创新单克隆抗体的挑战,SYnAbs公司开发了一整套技术,结合了:


(1)通过专有技术进行创新抗原设计SYnDNA载体、SYnCell同基因细胞系和特殊佐剂;

(2)专有大鼠LOU物种、野生型、敲除型和多种转基因物种(包括 ATX-Gx 转基因小鼠平台)的多物种免疫;

(3)独特的免疫策略打破免疫耐受并触发特定表位;

(4)稀有B细胞群的选择和分离。


部分单克隆抗体:

Rat anti-human CD2 Siplizumab (LO-CD2a/BTI-322)

Mouse anti-human chemokine receptor

Rat anti-Valproic acid hapten,Rat anti-galactomannan

IgG2b kappa rat anti-His tag (N-ter & C-ter)

IgG1 rat anti-human IgG4

IgG1 kappa rat anti-dinitrophenyl hapten


创新型一抗:

(1)高价值一抗针对复杂和小分子的一抗

(2)同型对照和不相关抗体(抗DNP)


大量二抗:SYnAbs公司为生物技术、制药和体外诊断公司提供大量二抗单克隆抗体目录(超过一百种二抗免疫球蛋白)。

< " data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理SYnAbs品牌抗体">
艾美捷科技代理SYnAbs品牌抗体
...
阅读详情
MicroFIT logo.png

<

艾美捷科技代理MicroFIT品牌全系列产品


MicroFIT是一家在生物/医疗领域具有显著影响力的企业,专注于基于模拟人体环境和组织的平台技术,致力于为生物医疗领域提供创新的产品和服务。公司以成为“基于Bio-Convergence技术的仿生平台领先企业”为目标,不断探索和研发,旨在成长为一家提供个性化医疗所需仿生平台的全球性公司。


MicroFIT页面.png


▍MicroFIT产品线

StemFIT 3D-Plastic系列

StemFIT 3D-Plastic系列产品采用PS(聚苯乙烯)材料设计,融合了多种实用功能,旨在使大规模3D细胞培养变得更加容易、高效和经济。能广泛应用于再生医学、精准医疗、疾病建模、发育生物学、毒物学、宿主-微生物组相互作用、药物发现和基因编辑等多个领域。


型号H389600P-6 孔H389600P-单人
材料聚苯乙烯聚苯乙烯
特征大规模培养, 经济实惠,易于移液, 疏水性大众培养, 经济实惠,易于移液, 疏水性
井数量每个 2,334389 个
井径600 微米600 微米
单元格数量≥ 1.2 x 106≥ 1.2 x 106
细胞接种培养基的体积1 毫升1 毫升
细胞培养基体积3 ~ 8 毫升3 毫升
包装3 包/箱20 个 EA/CS,40 个 EA/CS


● StemFIT 3D®

StemFIT 3D®是一款创新性的三维细胞培养板,带有凹形微孔的微孔板,其核心原理在于利用这些微孔将孔内的细胞浓缩,进而培养细胞聚集体。使细胞能够在三维空间内相互作用,更好地模拟了体内细胞的生长环境。StemFIT 3D®在三个维度上形成细胞聚集体,允许细胞向各个方向生长并与周围环境相互作用,通过扩散和传递为细胞提供营养、氧气和药物,从而提供更接近生物体真实情况的仿生环境。


型号井型井数井径细胞数量播种培养基体积总培养基体积
H1613200Hexagon1613200 μm≥ 6.0 x 105500 μl1 ml
H853400Hexagon853400 μm≥ 1.2 x 1061 ml1.5 ml
H389600L/H389600HHexagon389600 μm≥ 1.2 x 1061 mlH389600L-1.3 ml;H389600H-1.7 ml
H449800Hexagon449800 μm≥ 2.4 x 1061 ml4 ml
H2951000Hexagon2951000 μm≥ 2.4 x 1062 ml4 ml
C100600Circle100600 μm≥ 6.0 x 1052 ml700 μl
C163000Circle163,000 μm2.5 x 105 / well20 μl / well5 ml
C253000Circle253,000 μm2.5 x 105 / well20 μl / well3 ml


● NanoFIT 3D®系列

NanoFIT 3D®系列细胞培养板通过实现线或柱结构的均匀纳米图案来提供仿生界面。这种独特的纳米拓扑结构能够模拟细胞外环境,允许科研人员通过诱导细胞调整其形态和排列,从而更精准地控制和分析特定细胞的反应。它有可能基于纳米图案最大限度地维持和分化细胞,在体内提供类似于ECM(细胞外基质)的环境,使细胞的形态和功能更接近体内真实状态。能维持细胞干性与分化;调节特定细胞靶向;多样化培养形式并且拥有专利技术保障。


TypePatternSizeCat. No.
Sheet (Polydimethylsiloxane)Line250 nmN-Line250S
Sheet (Polydimethylsiloxane)Line400 nmN-Line400S
Sheet (Polydimethylsiloxane)Post250 nmN-Post250S
Sheet (Polydimethylsiloxane)Post400 nmN-Post400S
Sheet (Polydimethylsiloxane)Flat250 nmN-Flat250S
Sheet (Polydimethylsiloxane)Flat400 nmN-Flat400S
Dish (Polystyrene)Line400 nmN-Line400P


● 微珠芯片

微珠芯片是一种专为大规模生产微型珠子而设计的微流控装置。它采用先进的材料和工艺制造,旨在利用胶原蛋白、PEGDA、PLGA等多种水凝胶材料,实现高效、精准的大规模微粒生产。具有卓越的耐化学性;精密的珠子生产能力;材料坚固耐用且可重用。


● PDMS膜

PDMS膜,即聚二甲基硅氧烷膜,作为应用最为广泛的硅基有机聚合物之一,、PDMS膜具有柔软弹性,能够轻松实现大幅度的拉伸变形,且在拉伸过程中仍能保持较好的物理性能和稳定性;具备超薄膜的结构特点,厚度可以做到极薄,在保证基本功能的前提下,最大程度地减少材料的使用和空间的占用;拥有良好的透气性,它允许气体分子自由通过,在生物相容性应用中,能为细胞提供适宜的气体交换环境,促进细胞的生长和代谢;在微流体装置等应用里,也能保证气体的顺畅流通,维持系统的稳定运行;拥有优异的光学透明性,几乎不会对光线的传播产生干扰;对生物组织无毒无害,不会引发明显的免疫反应,可安全地应用于生物医学领域。

<
MaterialDiameterThickness
PDMS50 mm / 1.97 inch10 μm
PDMS50 mm / 1.97 inch30 μm
PDMS50 mm / 1.97 inch50 μm


 PDMS定位

PDMS(聚二甲基硅氧烷)作为一种硅基弹性体,拥有高光学透明度,能让研究人员清晰地观察芯片内发生的微观反应和现象;化学稳定性极佳,可在各种化学环境下保持性能稳定;出色的变形性使其能够适应不同的实验需求和操作条件;优异的生物相容性则为生物样本的研究提供了安全可靠的环境。PDMS片上实验室采用了世界领先的PDMS LOC(Lab - on - a - Chip)技术。这项技术实现了在微米尺度上构建具有卓越成型性的纳米·微结构,将复杂的实验室功能集成到一个小小的芯片之上。


 SU-8微型模具

SU-8微型模具是一种感光聚合物模具,专门用于芯片实验室的微图案铸造。它采用环氧树脂基负光刻胶SU-8作为主要材料,通过精密的光刻工艺在晶圆上制造出微图案。相较于其他模具材料,SU-8微型模具的生产速度更快。该模具的高度可高达1,000μm,能够满足制造具有较大高度微结构的需求。这种模具在微流控芯片、生物传感器、微机电系统(MEMS)等领域的生产制造中发挥着重要作用。


通道高度晶圆尺寸
100 μm 以下4英寸1层
100 μm 以下6英寸1层
110 - 200 微米4英寸1层
110 - 200 微米6英寸1层
210 - 300 微米4英寸2 层
310 - 500 微米4英寸超过 2 层
510 - 800 微米4英寸超过 3 层


 晶圆厂工艺

在半导体产业飞速发展的今天,高效、精准且可靠的制造服务至关重要。MicroFIT凭借其专业的技术和丰富的经验,提供一站式的半导体制造服务,采用分布式外包流程,为客户解决各种制造难题。包括以下服务:

● 光刻:将精心设计的图案精准转移到晶圆上,这是半导体制造的关键起始步骤,为后续的工艺奠定基础,确保图案的高精度和准确性。

● 镀膜:通过各种工艺使金属、聚合物等材料以薄膜形式均匀沉积在硅衬底上,为芯片提供必要的功能层和保护层,增强芯片的性能和稳定性。

● 蚀刻:精确去除必要电路图案外的其余部分,可选择干蚀刻或湿蚀刻方法,以实现对材料的精细加工,塑造出所需的微纳结构。

● 粘接:在半导体制造中,用于将芯片与基板牢固粘合;在微流控器件制造里,用于通道形成后的处理,确保器件各部分之间的可靠连接和密封性。

● 切割:把在半导体晶片加工中制造的器件在图案形成后分离成一定的尺寸,为后续的封装和测试等步骤做准备。

● CMP(化学机械抛光):通过化学和物理过程的结合,对晶圆或玻璃基板进行抛光压平,使表面达到极高的平整度,满足半导体器件制造的严格要求。

" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理MicroFIT品牌全系列产品">
艾美捷科技代理MicroFIT品牌全系列产品
...
阅读详情
Megazyme-by-Neogen_Logo.jpgexocell.jpg

<

艾美捷科技代理MegaZyme品牌


Megazyme 成立于1988年,位于爱尔兰,是一家全球知名的酶及酶法分析试剂盒的生产厂家,专注于制造和供应高品质和创新的检测试剂盒和生化分析试剂。Megazyme 产品线以其卓越的高纯度酶制剂而闻名,是全球多种碳水化合物及酶底物产品的核心供应商。该公司目前提供了超过70种诊断试剂盒和超过300种其他试剂和底物。


Megazyme产品广泛应用的领域:

1)食品和饮料‌:用于检测和分析食品中的成分和添加剂。

2)生物燃料‌:用于生物燃料的开发和生产过程中的质量控制。

3)动物饲料‌:确保饲料成分的安全和营养价值。

4)葡萄酒和酿造‌:用于葡萄酒的发酵和质量控制。

5)乳制品和谷类食品‌:用于乳制品和谷类食品的营养成分分析。


正文图.png


Megazyme产品线包括:

● 检测试剂盒:涵盖膳食纤维、淀粉、糖类、醇类、有机酸、酶活性等领域;

● 高纯度酶制剂与生化底物:生产供应种类繁多的高纯度酶,包括:碳水化合物水解酶、氧化还原酶、蛋白酶 & 脂肪酶以及其他特异性酶。此外,Megazyme还提供各种高纯度的酶作用底物,特别是碳水化合物底物;

● 分析标准品与参比物质:提供与检测试剂盒配套或独立的高纯度、认证的分析标准品,包括分析标准缓冲液,辅助因子与染色剂等;

● 配套仪器与自动化解决方案:Megazyme 也开发或整合了部分专用仪器,用于高通量处理特定检测 (如膳食纤维) 中的复杂步骤。


" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理MegaZyme全系列产品">
艾美捷科技代理MegaZyme全系列产品
...
阅读详情
66979f745b68d.jpg

艾美捷科技代理LifeSensors品牌。


LifeSensors成立于1996年,位于美国宾夕法尼亚州费城,是一家为药物发现与研究提供方法和可行性技术方法的生物技术公司。公司致力于为泛素和泛素蛋白酶体通路研究领域提供高品质

的抗体、酶、蛋白质等试剂和试剂盒,产品,是泛素研究者的好选择。


其原核和真核蛋白表达系统SUMOpro和SUMOstar已被世界范围内的学术、政府研究机构和制药、生物技术公司广泛应用。通过提供创新的研究工具,LifeSensors已成为泛素和泛素样蛋

白途径的优质供应商。

LifeSensors公司目前主要的产品有400多种,其产品主要覆盖泛素和泛素蛋白酶体通路等科学应用领域,并且产品线在不断的扩大中。公司开创了两大独家技术平台:用于细胞信号和药物

发现的泛素蛋白酶体系统(UPS),以及增强目的蛋白在大肠杆菌、酵母、昆虫和哺乳动物细胞中表达与纯化的SUMO融合表达系统。泛素蛋白酶体系统正在成为继激酶之后,药物发现的下

一个机遇,必将成为未来许多新型药物的创新来源。作为泛素蛋白领域的先驱公司,药物的发现、分析化合物以及去泛素酶和泛素化酶的高通量筛选正是LifeSensors创新技术的真正亮点。

此外,LifeSensors还为泛素的蛋白质组学提供众多定制技术服务,并且已经开发了各种各样的测定细胞中的生理底物或生物标志物的方法。

< " data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理LifeSensors品牌">
艾美捷科技代理LifeSensors品牌
...
阅读详情
AllerMAbs.jpg

艾乐美生物科技有限公司(AllerMAbs Co., Ltd.)成立于2015年,是台湾一家专注于生产高亲和力、高纯度并具有过敏原特异性的嵌合人类IgE单克隆抗体的生物公司。公司创办人团队在科研过程中发现市面上缺乏多样的IgE单克隆抗体,特別是具有过敏原特异性的人IgE 单抗。如果能制备出这种抗体,将有助于IgE 相关领域的研究工作。因此,AllerMAbs公司团队开始思考与研究利用基因克隆动物来制造人类 IgE 抗体的可行性,经过数年的努力于 2014年开发出人类IgE 抗体基因嵌入小鼠,通过杂交瘤技术 (Hybridoma technology),成功地研制出分泌嵌合人类IgE 单抗的 IgE 杂交瘤与纯化 IgE 抗体。经测试,此种嵌合人类IgE 单抗的物化性质与对免疫细胞的活性,皆与人类IgE 抗体一致,研究成果于2015 年发表在国际学术期刊上。

 

AllerMAbs的产品解决了目前人类IgE抗体不易制备的问题,让嵌合人类IgE抗体可以成为人类IgE抗体的替代品,并提供一个更稳定、更符合血清IgE检测系统的校正品,让临床血清IgE的检测结果更加准确与可靠。

 

其利用动物基因转殖技术,将组成人类IgE抗体分子的ε重链(Heavy chain)和κ轻链(Light chain)的编码基因(Encoding genes),分別嵌入(Knock-in)小鼠胚胎干细胞(Embryonic stem cells, ES cells)的γ1重链和κ轻链基因的位置,接着把胚胎干细胞分別植入孕母鼠体内,并将其带有嵌入基因之成鼠交互配种,最后得到带有人类IgE抗体重链和轻链基因的基因嵌入小鼠(HεκKI mice),且体内能制造完整的嵌合人类IgE抗体分子。

 

技术优势

容易制备IgE杂交瘤与IgE单抗

过敏原特异性

良好的亲和力与专一性

高纯度与高稳定性

可结合至嗜碱性粒细胞上的IgE受体与刺激細胞

可大量生产与高浓度制备

非人类血液来源(相较于血清IgE抗体)

适合用作检测用的校正品

" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="AllerMAbs">
AllerMAbs
...
阅读详情
艾美捷官网上传2.5:1.jpgexocell.jpg

艾美捷科技代理Crystal Positioning Systems (CPS)品牌

Crystal Positioning Systems (CPS)是专业蛋白结晶设备生厂商,包括:Puck 样品槽、液氮箱、运输箱、样品储存和转移用的工具。Crystal Positioning Systems (CPS) 是一家专注于为X射线晶体学和结构生物学领域提供高精度样品定位和自动化解决方案的公司,CPS 的产品旨在帮助科学家在蛋白质晶体学、材料科学和其他相关领域的研究中,实现更高效、更精确的样品定位和数据收集。公司以其创新的技术、高质量的产品和对客户需求的深刻理解而闻名。核心业务领域:

(1)高精度样品定位系统:CPS 提供用于X射线衍射仪的高精度样品定位系统,支持蛋白质晶体和小分子晶体的精确对准。这些系统能够显著提高数据收集的效率和准确性。

(2)自动化晶体成像系统:公司开发了自动化晶体成像系统,用于实时监测晶体生长过程,帮助科学家优化晶体生长条件。这些系统通常与X射线衍射仪集成,支持从晶体生长到数据收集的全流程自动化。

(3)机器人样品处理系统:CPS 提供机器人样品处理系统,用于高通量晶体筛选和数据收集。这些系统能够自动处理大量样品,显著提高实验效率。




" data-original="http://fabgennix.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Crystal Positioning Systems (CPS)品牌">
艾美捷科技代理Crystal Positioning Systems (CPS)品牌
...
阅读详情

Copyright © 2026 Powered by FabGennix中国区代理商/公司/官网   鄂ICP备10204150号-10 sitemap